UK markets closed


LSE - LSE Delayed price. Currency in PLN
Add to watchlist
760.00+760.00 (-)
At close: 05:11PM GMT


ul. Forteczna 35-37
Torun 87-100
48 56 669 4000

Full-time employees3,981

Key executives

NameTitlePayExercisedYear born
Mr. Piotr SucharskiPresident of the Management Board & General Director2.42MN/AN/A
Mr. Grzegorz DzikVP of Management Board & CFO1.32MN/AN/A
Mr. Krzysztof MiszewskiVice President of Management Board for Operations1.56MN/AN/A
Mr. Daniel WojtkiewiczVice President of the Management Board & Director of the Sales Division659kN/AN/A
Ms. Julita CzyzewskaVice President of the Management Board for the Patient Area63kN/AN/A
Mr. Roman DudzikVice President of the Management Board the Board of Directors for the IT Division484kN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in PLN.


NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies, hospitals, and other outpatient medical care facilities in Poland. It operates through Pharmaceutical Wholesale, Manufacture of Pharmaceuticals, Outpatient Medical Care Clinics, Clinical Trials, and Insurance Activities segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, agency, financial, road cargo transport, medical practice, software, hospital, property management, scientific research and development, and IT services; clinical and experimental development services in biotechnology; therapeutic research services for new drug and medical product developments; and health, property, and other personal insurance products. In addition, it produces Rx, OTC medicines, dietary supplements, medical devices, and dermo cosmetics; leases intellectual property and related products; retails medical products, such as orthopedic devices; and operates outpatient care clinics. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.

Corporate governance

NEUCA S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.